0001225208-24-001949.txt : 20240213 0001225208-24-001949.hdr.sgml : 20240213 20240213165134 ACCESSION NUMBER: 0001225208-24-001949 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240213 FILED AS OF DATE: 20240213 DATE AS OF CHANGE: 20240213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOBO DONALD E JR CENTRAL INDEX KEY: 0001196661 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15525 FILM NUMBER: 24627004 MAIL ADDRESS: STREET 1: C/O EDWARDS LIFESCIENCES STREET 2: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Edwards Lifesciences Corp CENTRAL INDEX KEY: 0001099800 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 364316614 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: 9492502500 MAIL ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP. DATE OF NAME CHANGE: 20090225 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP DATE OF NAME CHANGE: 20000203 FORMER COMPANY: FORMER CONFORMED NAME: CVG CONTROLLED INC DATE OF NAME CHANGE: 19991126 4 1 doc4.xml X0508 4 2024-02-13 0001099800 Edwards Lifesciences Corp EW 0001196661 BOBO DONALD E JR ONE EDWARDS WAY IRVINE CA 92614 1 CVP,Strategy/Corp Development 1 Common Stock 2024-02-13 4 M 0 11000.0000 36.7500 A 50502.6931 D Common Stock 2024-02-13 4 S 0 470.0000 86.3457 D 50032.6931 D Common Stock 2024-02-13 4 S 0 10530.0000 85.8094 D 39502.6931 D Common Stock 38505.4844 I 401(k) Common Stock 135152.0000 I By Trust Employee Stock Option (Right to Acquire) 36.7500 2024-02-13 4 M 0 11000.0000 0.0000 D 2017-06-11 2024-05-10 Common Stock 11000.0000 27000.0000 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 2, 2023. This transaction was executed in multiple trades at prices ranging from $86.34 to $86.35. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $85.33 to $86.30. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Reflects shares represented on the most recent statement of the Issuer's 401(k) Plan Administrator. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Linda J. Park, Attorney-in-Fact 2024-02-13